Paltieli Y, Degani S, Zrayek A, Gonen R, Lewinski M R, Zamberg Y, Ohel G
Department of Obstetrics and Gynecology, Bnai-Zion Medical Center and The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Ultrasound Obstet Gynecol. 2002 Mar;19(3):269-73. doi: 10.1046/j.1469-0705.2002.00607.x.
To assess the performance of the UltraGuide 1000 system, and to compare ultrasound-guided freehand mid-trimester amniocentesis with and without the new guidance system.
One hundred and sixty-nine women referred for mid-trimester genetic amniocentesis were divided into two groups: a control group of 99 women who underwent the procedure by the freehand technique with scored needles and 70 patients who had the procedure carried out with the aid of a guidance system (UltraGuide 1000) with non-scored needles. The procedures were compared for duration, number of punctures and repositionings of the needle, the visibility of the needle during the puncture and the number of bloody taps.
The study group had significantly lower rates of reinsertion (none vs. 7.1%), repositioning (7.1% vs. 17.7%), bloody taps (none vs. 6.1%), touching the fetus (5.7% vs. 22.2%) and prolonged duration of the procedure (4.3% vs. 14.4%) compared with the control group. There was one fetal loss in the control group. Non-visibility of the needle before reaching the amniotic sac occurred in 18.6% of cases in the study group and in 38.4% of cases in the control group.
The new guidance system combines the benefits of an attached guide with the flexibility of the 'freehand' technique. Use of the new guidance system for mid-trimester genetic amniocentesis increases needle visibility and lowers the incidence of common complications.
评估UltraGuide 1000系统的性能,并比较使用和不使用新引导系统进行超声引导下孕中期羊水穿刺术的情况。
169名被转诊进行孕中期基因羊水穿刺术的女性被分为两组:对照组99名女性采用带刻度针的徒手技术进行该操作,70名患者借助引导系统(UltraGuide 1000)使用无刻度针进行该操作。比较两组操作的持续时间、穿刺次数和针的重新定位次数、穿刺过程中针的可视性以及血性穿刺的次数。
与对照组相比,研究组的再次插入率(0%对7.1%)、重新定位率(7.1%对17.7%)、血性穿刺率(0%对6.1%)、触及胎儿率(5.7%对22.2%)和操作持续时间延长率(4.3%对14.4%)均显著降低。对照组有1例胎儿丢失。研究组18.6%的病例和对照组38.4%的病例在到达羊膜囊之前针不可见。
新的引导系统结合了附着式引导器的优点和“徒手”技术的灵活性。在孕中期基因羊水穿刺术中使用新的引导系统可提高针的可视性并降低常见并发症的发生率。